Skip to main content
Top
Literature
1.
go back to reference Glynn J (2012) Remembering my sister Rosalind Franklin. Lancet 379:1094–1095CrossRef Glynn J (2012) Remembering my sister Rosalind Franklin. Lancet 379:1094–1095CrossRef
2.
go back to reference Glynn J (2008) Rosalind Franklin: 50 years on. Notes Rec R Soc 62:253–255CrossRef Glynn J (2008) Rosalind Franklin: 50 years on. Notes Rec R Soc 62:253–255CrossRef
3.
go back to reference Conti AA (2011) Reconstructing medical history: historiographical features, approaches and challenges. Clin Ter 162:133–136PubMed Conti AA (2011) Reconstructing medical history: historiographical features, approaches and challenges. Clin Ter 162:133–136PubMed
4.
go back to reference Conti AA (2020) Nobel Prizes in Medicine as an overview on XX and XXI centuries biomedicine and health sciences: historical and epistemological considerations. Acta Biomedica 91, in press. Conti AA (2020) Nobel Prizes in Medicine as an overview on XX and XXI centuries biomedicine and health sciences: historical and epistemological considerations. Acta Biomedica 91, in press.
5.
go back to reference Norrby E (2010) Nobel prizes and life sciences. World Scientific Publishing Company, SingaporeCrossRef Norrby E (2010) Nobel prizes and life sciences. World Scientific Publishing Company, SingaporeCrossRef
Metadata
Title
“A hundred years since the birth of Rosalind Elsie Franklin, a brilliant and gifted scientist”
Author
Andrea Alberto Conti
Publication date
01-03-2021
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 2/2021
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-020-02449-2

Other articles of this Issue 2/2021

Internal and Emergency Medicine 2/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine